These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 880745)
1. Effects of water-soluble adjuvant (WSA) on New Zealand (NZB X NZW) F1 hybrid mice. Abe C; Chia D; Barnett EV; Pearson CM; Shiokawa Y Clin Immunol Immunopathol; 1977 Jul; 8(1):17-27. PubMed ID: 880745 [No Abstract] [Full Text] [Related]
2. Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice. Yoshida H; Kohno A; Ohta K; Hirose S; Maruyama N; Shirai T J Immunol; 1981 Aug; 127(2):433-7. PubMed ID: 6972963 [No Abstract] [Full Text] [Related]
3. Genetic studies on the skin lupus band test in New Zealand mice. Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675 [TBL] [Abstract][Full Text] [Related]
4. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455 [TBL] [Abstract][Full Text] [Related]
5. The effect of a water soluble adjuvant on the immune response to synthetic polypeptides. Maron R; Mozes E; Fuchs S; Sela M; Chedid L Ann Immunol (Paris); 1978; 129 C(4):489-97. PubMed ID: 697316 [TBL] [Abstract][Full Text] [Related]
6. Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA). Bassi N; Luisetto R; Del Prete D; Ghirardello A; Ceol M; Rizzo S; Iaccarino L; Gatto M; Valente ML; Punzi L; Doria A Lupus; 2012 Feb; 21(2):203-9. PubMed ID: 22235054 [TBL] [Abstract][Full Text] [Related]
7. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900 [TBL] [Abstract][Full Text] [Related]
8. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. Gilliam JN J Invest Dermatol; 1975 Jul; 65(1):154-61. PubMed ID: 1097541 [TBL] [Abstract][Full Text] [Related]
9. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860 [TBL] [Abstract][Full Text] [Related]
10. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus. Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477 [TBL] [Abstract][Full Text] [Related]
11. Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. Bassi N; Luisetto R; Ghirardello A; Gatto M; Bottazzi B; Shoenfeld Y; Punzi L; Doria A Reumatismo; 2012 Dec; 64(6):380-7. PubMed ID: 23285482 [TBL] [Abstract][Full Text] [Related]
12. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease. Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of systemic lupus erythematosus--studies using disease models. 2. Suppression of anti-ds DNA antibody formation in NZB/W mice and improvement of glomerulonephritis]. Okuhira H; Terada E; Fukuda K; Ogita T; Miyamoto A Nihon Rinsho; 1984 Dec; 42(12):2795-800. PubMed ID: 6530764 [No Abstract] [Full Text] [Related]
14. Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Shirai T; Ohta K; Kohno A; Furukawa F; Yoshida H; Maruyama N; Hirose S Arthritis Rheum; 1986 Feb; 29(2):242-50. PubMed ID: 3954806 [TBL] [Abstract][Full Text] [Related]
16. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease. Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709 [TBL] [Abstract][Full Text] [Related]
17. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals. Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971 [TBL] [Abstract][Full Text] [Related]
18. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice. Wellmann U; Letz M; Schneider A; Amann K; Winkler TH Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187 [TBL] [Abstract][Full Text] [Related]
19. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]